Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad?
作者信息
Versmissen Jorie, Verdonk Koen, Lafeber Melvin, van den Akker Johannes P C, Hunfeld Nicole G M, Hoorn Ewout J, Danser A H Jan
机构信息
Department of Internal Medicine.
Department of Hospital Pharmacy.
出版信息
J Hypertens. 2020 Jun;38(6):1196-1197. doi: 10.1097/HJH.0000000000002472.
Abstract
摘要
相似文献
1
Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad?严重急性呼吸综合征冠状病毒2感染中的血管紧张素转换酶2：是好是坏？
J Hypertens. 2020 Jun;38(6):1196-1197. doi: 10.1097/HJH.0000000000002472.
2
Letter by Weir Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2".韦尔就《血管紧张素转换酶2：SARS-CoV-2受体及肾素-血管紧张素系统的调节因子：庆祝ACE2发现20周年》一文所写的信
Circ Res. 2020 Jul 3;127(2):e44-e45. doi: 10.1161/CIRCRESAHA.120.317294. Epub 2020 Jul 2.
3
Response by Gheblawi et al to Letter Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2".格布拉维等人对关于“血管紧张素转换酶2：SARS-CoV-2受体与肾素-血管紧张素系统调节剂：庆祝血管紧张素转换酶2发现20周年”一文的信件的回复
Circ Res. 2020 Jul 3;127(2):e46-e47. doi: 10.1161/CIRCRESAHA.120.317332. Epub 2020 Jul 2.
4
Clinical significance of angiotensin-converting enzyme 2 receptors for severe acute respiratory syndrome coronavirus 2 (COVID-19) on peripheral small-fiber sensory neurons is unknown today.血管紧张素转换酶2受体在严重急性呼吸综合征冠状病毒2（COVID-19）对外周小纤维感觉神经元中的临床意义目前尚不清楚。
Pain. 2020 Nov;161(11):2431-2433. doi: 10.1097/j.pain.0000000000002050.
5
Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.对近期有关血管紧张素转换酶2（ACE2）和肾素-血管紧张素系统阻滞剂与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染相关性的评论的回应
Drug Dev Res. 2020 Sep;81(6):643-646. doi: 10.1002/ddr.21672. Epub 2020 Apr 17.
6
Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link.血管紧张素转换酶2、性别差异与2019冠状病毒病：缺失的环节
Int J Cardiol. 2021 Jan 1;322:293. doi: 10.1016/j.ijcard.2020.09.018. Epub 2020 Sep 10.
7
Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy.作为一种潜在的 COVID-19 疗法，竞争性结合 SARS-CoV-2 的诱饵 ACE2 表达细胞外囊泡。
Clin Sci (Lond). 2020 Jun 26;134(12):1301-1304. doi: 10.1042/CS20200623.
8
Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research.新型冠状病毒肺炎与血管紧张素转换酶2（ACE2）：研究领域
Heart Lung. 2020 Jul-Aug;49(4):351. doi: 10.1016/j.hrtlng.2020.04.012. Epub 2020 Apr 20.
9
What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?血管紧张素转换酶2（ACE2）在合并糖尿病的高血压患者感染新型冠状病毒肺炎（COVID-19）中起什么作用？
Can J Cardiol. 2020 Jun;36(6):969.e3. doi: 10.1016/j.cjca.2020.03.049. Epub 2020 Apr 8.
10
Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.血管紧张素转化酶 2：新型严重急性呼吸综合征冠状病毒 2 感染的旧门。
Rev Med Virol. 2020 Sep;30(5):e2122. doi: 10.1002/rmv.2122. Epub 2020 Jun 30.
引用本文的文献
1
SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations.SARS-CoV-2 与中枢神经系统：出血相关神经后果及治疗考虑的新见解。
Ageing Res Rev. 2022 Sep;80:101687. doi: 10.1016/j.arr.2022.101687. Epub 2022 Jul 16.
2
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study.在 COvid MEdicaTion（COMET）研究中，入院前使用血管紧张素转换酶抑制剂或血管紧张素 II 受体阻滞剂与 COVID-19 的临床病程之间没有关联。
Br J Clin Pharmacol. 2021 Aug;87(8):3301-3309. doi: 10.1111/bcp.14751. Epub 2021 Feb 18.
3
Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain.先前合并症和慢性药物使用对成年人 COVID-19 风险的影响：西班牙塔拉戈纳的一项基于人群的队列研究。
BMJ Open. 2020 Dec 10;10(12):e041577. doi: 10.1136/bmjopen-2020-041577.
4
Does intestinal dysbiosis contribute to an aberrant inflammatory response to severe acute respiratory syndrome coronavirus 2 in frail patients?肠道菌群失调是否会导致脆弱患者对严重急性呼吸综合征冠状病毒 2 产生异常炎症反应？
Nutrition. 2020 Nov-Dec;79-80:110996. doi: 10.1016/j.nut.2020.110996. Epub 2020 Sep 1.
5
Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.使用不同的抗高血压药物与高血压人群 COVID-19 风险：西班牙加泰罗尼亚南部的一项基于人群的队列研究。
J Clin Hypertens (Greenwich). 2020 Aug;22(8):1379-1388. doi: 10.1111/jch.13948. Epub 2020 Jul 25.
6
COvid MEdicaTion (COMET) study: protocol for a cohort study.新冠药物（COMET）研究：一项队列研究的方案
Eur J Hosp Pharm. 2020 Jul;27(4):191-193. doi: 10.1136/ejhpharm-2020-002329.
Zotero 插件